Bayer Fights To Overturn Xarelto Blood Thinner Patent Loss
Pharma giant Bayer AG took its fight against a slew of generic-drug makers to keep its patent over its blockbuster drug Xarelto to the Court of Appeal on Thursday, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article